Extending the life span of dendritic cells improves the potency of cancer vaccines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Nestle, F.O., Banchereau, J. & Hart, D. Nat. Med. 7, 761–765 (2001).
Park, D., Lapteva, N., Seethammagari, M., Slawin, K.M. & Spencer, D.M. Nat. Biotechnol. 24, 1581–1590 (2006).
Banchereau, J. & Steinman, R.M. Nature 392, 245–252 (1998).
Reis e Sousa, C. Nat. Rev. Immunol. 6, 476–483 (2006).
Schadendorf, D. et al. Ann. Oncol. 17, 563–570 (2006).
Small, E.J. et al. J. Clin. Oncol. 24, 3089–3094 (2006).
Srivastava, P.K. Curr. Opin. Immunol. 18, 201–205 (2006).
Josien, R. et al. J. Exp. Med. 191, 495–502 (2000).
Lowy, D.R. & Schiller, J.T. J. Clin. Invest. 116, 1167–1173 (2006).
Boon, T., Coulie, P.G., Van den Eynde, B.J. & van der Bruggen, P. Annu. Rev. Immunol. 24, 175–208 (2006).
Peggs, K.S., Quezada, S.A., Korman, A.J. & Allison, J.P. Curr. Opin. Immunol. 18, 206–213 (2006).
Pulendran, B. & Ahmed, R. Cell 124, 849–863 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nestle, F. A new lease on life for dendritic cell vaccines?. Nat Biotechnol 24, 1483–1484 (2006). https://doi.org/10.1038/nbt1206-1483
Issue Date:
DOI: https://doi.org/10.1038/nbt1206-1483